Toshiba signs contract with Magnet GPO
Toshiba America Medical Systems recently signed a three-year, sole-source agreement to provide cardiovascular and diagnostic ultrasound systems to Magnet, a group purchasing organization. Under the contract, Magnet’s 12,000 hospital and clinic
Toshiba America Medical Systems recently signed a three-year, sole-source agreement to provide cardiovascular and diagnostic ultrasound systems to Magnet, a group purchasing organization. Under the contract, Magnets 12,000 hospital and clinic members will be able to purchase scanners from Toshibas line of ultrasound products at negotiated group discount prices, including the digital PowerVision 8000 and 6000edp systems, as well as the Eccocee and JustVision scanners.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
